![Frédéric Lemay](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frédéric Lemay
Direttore/Membro del Consiglio presso AurKa Pharma, Inc.
Profilo
Frédéric Lemay currently works at Esperas Pharma Inc., as Director and AurKa Pharma, Inc., as Director.
Posizioni attive di Frédéric Lemay
Società | Posizione | Inizio |
---|---|---|
AurKa Pharma, Inc.
![]() AurKa Pharma, Inc. BiotechnologyHealth Technology AurKa Pharma, Inc. develops medication for cancer treatment. The company was founded by Caroline Fortier and is headquartered in Montreal, Canada. | Direttore/Membro del Consiglio | - |
Esperas Pharma Inc.
![]() Esperas Pharma Inc. Pharmaceuticals: MajorHealth Technology Esperas Pharma, Inc. manufactures and develops pharmaceutical products. The firm is created to develop one compound to proof-of-concept. It plans to develop, to proof-of-concept, a compound originally discovered through one of Lilly’s research and development programs, with the potential to treat certain types of cancers including triple negative breast cancer. The company was founded in 2015 and is headquartered in Montreal, Canada. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
AurKa Pharma, Inc.
![]() AurKa Pharma, Inc. BiotechnologyHealth Technology AurKa Pharma, Inc. develops medication for cancer treatment. The company was founded by Caroline Fortier and is headquartered in Montreal, Canada. | Health Technology |
Esperas Pharma Inc.
![]() Esperas Pharma Inc. Pharmaceuticals: MajorHealth Technology Esperas Pharma, Inc. manufactures and develops pharmaceutical products. The firm is created to develop one compound to proof-of-concept. It plans to develop, to proof-of-concept, a compound originally discovered through one of Lilly’s research and development programs, with the potential to treat certain types of cancers including triple negative breast cancer. The company was founded in 2015 and is headquartered in Montreal, Canada. | Health Technology |
- Borsa valori
- Insiders
- Frédéric Lemay